Why the study?
Does catheter ablation improve outcomes in patients with Arrhythmogenic right ventricular cardiomyopathy and recurrent ventricular tachycardia?
Does catheter ablation improve outcomes in patients with Arrhythmogenic right ventricular cardiomyopathy and recurrent ventricular tachycardia?
This review discusses the role, patient selection, technical issues, and outcomes of catheter ablation for managing recurrent ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Drug intolerance and incomplete VT control in ARVC may support ablation consideration; leaves open need for randomized outcome data.
Cipriani et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: